Yisheng Biopharma

Asia & Pacific Legal Chronicle. October 25, 2022

Matter YS Biopharma’s Merger with Summit Healthcare Acquisition Corp.

By Martina Bellini

Wilson Sonsini represented YS Biopharma on the deal. YishengBio Co., Ltd (YS Biopharma), a commercialization-stage biopharmaceutical company focusing on innovative vaccines and therapeutic biologics, and Summit...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Bloomberg’s Expansion Lease with SL Green Realty

Beacon Power Services’ Series A Raising

Benedict Realty Group’s $46.5 Million Acquisition of Multifamily Portfolio in Queens

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

YPF Luz’s US$420 Million Notes Issuance

Sixth Street’s Joint Venture with Copley Point

First Camp Group’s Bonds Offering

BIT ODD’s €17 Million Equity Round

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Firstsource Solutions UK Limited’s £42 Million Acquisition Of Ascensos Limited

Cathay Pacific Airways Ltd’s HK$6.732 Billion Convertible Bonds Issuance

China Water Affairs Group Limited’s HK$361 Million Exchangeable Bonds Offering

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Matter YS Biopharma’s Merger with Summit Healthcare Acquisition Corp.

Standard 1 Year Membership Required